iLASIK vision correction combines AMO technologies

Article

Advanced Medical Optics (AMO) continues its commitment to the LASIK industry by reaching out to a generation of nearly 290 million people worldwide who want better everyday vision.

Advanced Medical Optics (AMO) continues its commitment to the LASIK industry by reaching out to a generation of nearly 290 million people worldwide who want better everyday vision (iLASIK vision correction).

The iLASIK procedure is a consumer-facing brand platform that communicates the advantage of two of the company's technologies: femtosecond flap creation technology (IntraLase FS) and custom laser vision correction (Advanced CustomVue). The company presented the re-branded LASIK procedure during a user group meeting at the Hilton Riverside Hotel here prior to the American Academy of Ophthalmology annual meeting.

According to Ron Bache, global vice president of marketing, AMO refractive surgery, the procedure:

•Provides one integrated platform that features advanced technology at every step.

•Can be actively marketed to all segments of "Generation i" (college students, baby boomers, and even fighter pilots).

•Establishes the company as a committed partner that is making an unmatched investment in LASIK.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
© 2025 MJH Life Sciences

All rights reserved.